Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 135 participants.
Also called NCT07441200
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 135 participants
- Sponsor
- NS Pharma, Inc.
- Registry
-
NCT07441200
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Japan
- Registry status
- Recruiting
Technical summary
Registry record NCT07441200. Randomized; triple masking; primary purpose treatment. Start 2026-09-29 (actual); primary completion 2028-08-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)
- Condition
- Pulmonary Arterial Hypertension
- Intervention (Drug)
- NS-863 Low Dose
- Intervention (Drug)
- NS-863 High Dose
- Intervention (Drug)
- NS-863 Placebo
- Lead sponsor
- NS Pharma, Inc.
- Collaborator
- Nippon Shinyaku Co., Ltd.
Record details
- Record id
cardio:ct-nct07441200- Content hash
9da380f83e0d9dc692c4d73af1b6dfbc40608a84103949acb19ba6658de893a9